TABLE 2.
Disease | Methodology | Samples | Species | Key markers | Name | Ref. |
---|---|---|---|---|---|---|
Acute sterile skin inflammation | scRNA‐seq | Healthy skin and sterile skin wounds | Human | CD83, CCL22, CCR7, HLA‐DPA1 and LAMP3 | BDCA‐2+ CD123 int DCs | 41 |
Chronic inflammatory skin diseases | Smart‐seq2 | Healthy skin and atopic dermatitis and psoriasis lesions | Human | CCL17, LAMP3, BIRC3, CD200, IL‐15, IL‐32 | mregDCs | 46 |
Atopic dermatitis | 10× genomics | Lesional and nonlesional skin | Human | CCR7, CCL22, LAMP3, BIRC3 | LAMP3+CCR7+ DCs | 48 |
Polymicrobial sepsis | 10× genomics | Bone marrow, peripheral blood and spleen | Mouse | Cd86, Cd274, Marcks, Il4ra, Ccr7 | mregDCs | 49 |
Atherosclerosis | Public datasets | Mouse aortic leucocyte | Mouse | Fscn1, Ccr7 | mregDCs | 100 |
– | 10× genomics | Healthy corneal tissue | Human | LAMP3, BIRC3 | mregDCs | 45 |
Oropharyngeal diseases | 10× genomics | Tumour tissues and nonmalignant inflamed tissues | Human | LAMP3, CCR7, CCL19, CSF2RA | mregDCs | 28 |
Abbreviations: CCL, CC chemokine ligand; CCR, CC chemokine receptor; IL, interleukin; LAMP3, lysosomal‐associated membrane protein 3; scRNA‐seq, single‐cell RNA sequencing.